XML 44 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' equity
12 Months Ended
Dec. 31, 2015
Equity [Abstract]  
Shareholders' equity
Shareholders' equity
The authorized capital of the Company is comprised of 200 million common shares, $1 par value, and 500,000 preference shares. No preference shares have been outstanding during the last three years.
Basic earnings per share is computed by dividing net income by the weighted average number of common shares outstanding during the period. Diluted earnings per share is computed in the same manner except that the weighted average number of shares is increased to include dilutive securities. The following table provides a reconciliation of basic to diluted weighted average shares outstanding:
 
 
2015
 
2014
 
2013
 
(Shares in thousands)
Basic
41,558

 
41,366

 
41,105

Dilutive effect of share based awards
488

 
450

 
410

Dilutive effect of 3.875% Convertible Notes and warrants
6,012

 
4,654

 
2,178

Diluted
48,058

 
46,470

 
43,693


Weighted average shares that were antidilutive and therefore not included in the calculation of earnings per share were approximately 5.6 million, 6.3 million and 7.7 million for the years ended December 31, 2015, 2014 and 2013, respectively.
During periods in which the average market price of the Company's common stock is above the applicable conversion price of the Convertible Notes, or $61.32 per share, the impact of conversion would be dilutive and the dilutive effect of conversion of the Convertibles Notes is reflected in diluted earnings per share. As described in Note 8, the Company has elected the net settlement method of accounting for these conversions, under which the Company will settle the principal amount of the Convertible Notes in cash, and settle the excess conversion value in shares. As a result, in periods where the average market price of the Company's common stock is above $61.32 per share, under the treasury stock method, the Company calculates the number of shares issuable under the terms of the Convertible Notes based on the average market price of the stock during the period, and includes that number in the total diluted shares outstanding for the period. 
In connection with the issuance of the Convertible Notes, the Company entered into convertible note hedge and warrant agreements. The convertible note hedge agreements economically reduce the dilutive impact of the Convertible Notes. However, applicable accounting guidance requires the Company to separately analyze the impact of the warrant agreements on diluted weighted average shares outstanding, without giving effect to the anti-dilutive impact of the convertible note hedge agreements. The reductions in diluted shares that would result from giving effect to the anti-dilutive impact of the convertible note hedge agreements would have been 3.3 million, 2.7 million, and 1.6 million for the years ended December 31, 2015, 2014 and 2013, respectively. The treasury stock method is applied when the warrants are in the money and assumes the proceeds from the exercise of the warrants are used to repurchase shares based on the average stock price during the period. The exercise price of the warrants is approximately $74.65 per share of common stock. Shares issuable upon exercise of the warrants that were included in the total diluted shares outstanding were 2.7 million, 1.9 million and 0.6 million for the years ended December 31, 2015, 2014 and 2013, respectively. For additional information regarding the convertible notes and convertible note hedge and warrant agreements, see Note 8 to the consolidated financial statements.
The following tables provide information relating to the changes in accumulated other comprehensive income (loss), net of tax, for the years ended December 31, 2015 and 2014:

 
Cash Flow
Hedges
 
Pension and
Other
Postretirement
Benefit Plans
 
Foreign
Currency
Translation
Adjustment
 
Accumulated
Other
Comprehensive
Income (Loss)
 
(Dollars in thousands)
Balance at December 31, 2013
$

 
$
(97,037
)
 
$
(13,818
)
 
$
(110,855
)
Other comprehensive income (loss) before reclassifications
594

 
(47,536
)
 
(105,333
)
 
(152,275
)
Amounts reclassified from accumulated other comprehensive income (loss)
(594
)
 
2,829

 

 
2,235

Net current-year other comprehensive income (loss)

 
(44,707
)
 
(105,333
)
 
(150,040
)
Balance at December 31, 2014

 
(141,744
)
 
(119,151
)
 
(260,895
)
Other comprehensive income (loss) before reclassifications
(2,974
)
 
(1,276
)
 
(110,595
)
 
(114,845
)
Amounts reclassified from accumulated other comprehensive income
483

 
4,133

 

 
4,616

Net current-year other comprehensive (loss) income
(2,491
)
 
2,857

 
(110,595
)
 
(110,229
)
Balance at December 31, 2015
$
(2,491
)
 
$
(138,887
)
 
$
(229,746
)
 
$
(371,124
)


The following table provides information relating to the reclassifications of losses/(gains) in accumulated other comprehensive (loss) income into expense/(income), net of tax, for the years ended December 31, 20152014 and 2013 :

 
December 31, 2015
 
December 31, 2014
 
December 31,
2013
 
(Dollars in thousands)
Losses (gains) on foreign exchange contracts:
 
 
 
 
 
Cost of goods sold
$
679

 
$
(705
)
 
$
884

Total before tax
679

 
(705
)
 
884

Taxes
(196
)
 
111

 
46

Net of tax
$
483

 
$
(594
)
 
$
930

Amortization of pension and other postretirement benefits items:
 
 
 
 
 
Actuarial losses (1)
$
6,375

 
$
4,385

 
$
7,211

Prior-service credits (1)

 
(21
)
 
(21
)
Transition obligation

 

 
5

Total before tax
6,375

 
4,364

 
7,195

Tax benefit
(2,242
)
 
(1,535
)
 
(2,439
)
Net of tax
$
4,133

 
$
2,829

 
$
4,756

Total reclassifications, net of tax
$
4,616

 
$
2,235

 
$
5,686


(1)
These accumulated other comprehensive (loss) income components are included in the computation of net benefit cost of pension and other postretirement benefit plans (see Note 14 to the consolidated financial statements for additional information).


As previously disclosed, in 2007, the Company’s Board of Directors authorized the repurchase of up to $300 million of outstanding Company common stock. On February 23, 2016, the Company's Board of Directors terminated this authorization. No shares were purchased under this authorization.